186 related articles for article (PubMed ID: 23806809)
1. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.
Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH
J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
3. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs in plasma of patients with gastric cancers.
Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression.
Tchernitsa O; Kasajima A; Schäfer R; Kuban RJ; Ungethüm U; Györffy B; Neumann U; Simon E; Weichert W; Ebert MP; Röcken C
J Pathol; 2010 Nov; 222(3):310-9. PubMed ID: 20726036
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
[TBL] [Abstract][Full Text] [Related]
11. miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer.
Huang D; Wang H; Liu R; Li H; Ge S; Bai M; Deng T; Yao G; Ba Y
J Cell Biochem; 2014 Mar; 115(3):549-56. PubMed ID: 24122958
[TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.
Komatsu S; Ichikawa D; Tsujiura M; Konishi H; Takeshita H; Nagata H; Kawaguchi T; Hirajima S; Arita T; Shiozaki A; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2013 Jan; 33(1):271-6. PubMed ID: 23267156
[TBL] [Abstract][Full Text] [Related]
14. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
15. Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Nourse JP; Keane C; Bhatnagar A; Gandhi MK
Clin Cancer Res; 2014 Jan; 20(1):253-64. PubMed ID: 24222179
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-126 level combined with multi- detector computed tomography in the preoperative prediction of lymph node metastasis of gastric cancer.
Feng R; Lu S; Sah BK; Beeharry MK; Zhang H; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 22(4):773-780. PubMed ID: 29843221
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
Hou CG; Luo XY; Li G
Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
[TBL] [Abstract][Full Text] [Related]
19. The correlation between miRNA and lymph node metastasis in gastric cancer.
Huang KH; Lan YT; Fang WL; Chen JH; Lo SS; Li AF; Chiou SH; Wu CW; Shyr YM
Biomed Res Int; 2015; 2015():543163. PubMed ID: 25688358
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
